Acknowledgement
The authors wish to thank the biostatistician, Prof. Zhang Aihong (Department of Medical Statistics, Tongji University School of Medicine, Shanghai, China), for the design and guidance of statistical analysis in this study.
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34 https://doi.org/10.3322/caac.21551
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424 https://doi.org/10.3322/caac.21492
- Lee HY, Lee SW, Lee KS, Jeong JY, Choi JY, Kwon OJ, et al. Role of CT and PET imaging in predicting tumor recurrence and survival in patients with lung adenocarcinoma: a comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma. J Thorac Oncol 2015;10:1785-1794 https://doi.org/10.1097/JTO.0000000000000689
- Fan L, Fang M, Li Z, Tu W, Wang S, Chen W, et al. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule. Eur Radiol 2019;29:889-897 https://doi.org/10.1007/s00330-018-5530-z
- Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-285 https://doi.org/10.1097/JTO.0b013e318206a221
- Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q, et al. Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung. J Thorac Oncol 2015;10:1156-1162 https://doi.org/10.1097/JTO.0000000000000579
- Geles A, Gruber-Moesenbacher U, Quehenberger F, Manzl C, Al Effah M, Grygar E, et al. Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival. Virchows Arch 2015;467:675-686 https://doi.org/10.1007/s00428-015-1852-2
- Austin JH, Garg K, Aberle D, Yankelevitz D, Kuriyama K, Lee HJ, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology 2013;266:62-71 https://doi.org/10.1148/radiol.12120240
- Lee HY, Cha MJ, Lee KS, Lee HY, Kwon OJ, Choi JY, et al. Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas. J Thorac Oncol 2016;11:1064-1073 https://doi.org/10.1016/j.jtho.2016.03.011
- Nie K, Nie W, Zhang YX, Yu H. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Cancer Imaging 2019;19:47
- Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings. Onco Targets Ther 2017;10:153-163 https://doi.org/10.2147/OTT.S121059
- Limkin EJ, Sun R, Dercle L, Zacharaki EI, Robert C, Reuze S, et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol 2017;28:1191-1206 https://doi.org/10.1093/annonc/mdx034
- Miyamoto A, Kurosaki A, Fujii T, Kishi K, Homma S. HRCT features of surgically resected invasive mucinous adenocarcinoma associated with interstitial pneumonia. Respirology 2017;22:735-743 https://doi.org/10.1111/resp.12947
- Watanabe H, Saito H, Yokose T, Sakuma Y, Murakami S, Kondo T, et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma. Ann Thorac Surg 2015;99:975-981 https://doi.org/10.1016/j.athoracsur.2014.10.065
- Lee HY, Lee KS, Han J, Kim BT, Cho YS, Shim YM, et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer 2009;65:170-175 https://doi.org/10.1016/j.lungcan.2008.11.009
- Hsu CP, Chen CY, Hsu NY. Bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995;110:374-381 https://doi.org/10.1016/S0022-5223(95)70233-4
- Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243-1260 https://doi.org/10.1097/JTO.0000000000000630
- Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51 https://doi.org/10.1016/j.jtho.2015.09.009
- Liu Y, Kim J, Qu F, Liu S, Wang H, Balagurunathan Y, et al. CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma. Radiology 2016;280:271-280 https://doi.org/10.1148/radiol.2016151455
- Bland JM, Altman DG. Multiple significance tests: the bonferroni method. BMJ 1995;310:170
- Boland JM, Maleszewski JJ, Wampfler JA, Voss JS, Kipp BR, Yang P, et al. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis. Hum Pathol 2018;71:8-19 https://doi.org/10.1016/j.humpath.2017.08.002
- Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, et al. The IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:651-665 https://doi.org/10.1016/j.jtho.2016.01.025
- Luo J, Wang R, Han B, Zhang J, Zhao H, Fang W, et al. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma. J Cancer Res Clin Oncol 2016;142:1837-1845 https://doi.org/10.1007/s00432-016-2201-9
- Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61 https://doi.org/10.1097/JTO.0b013e3182769aa8
- Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-664 https://doi.org/10.1038/modpathol.2010.232
- Cai D, Li H, Wang R, Li Y, Pan Y, Hu H, et al. Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma. Onco Targets Ther 2014;7:2127-2132 https://doi.org/10.2147/OTT.S70984
- Akira M, Atagi S, Kawahara M, Iuchi K, Johkoh T. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. AJR Am J Roentgenol 1999;173:1623-1629 https://doi.org/10.2214/ajr.173.6.10584811
- Wong JS, Weisbrod GL, Chamberlain D, Herman SJ. Bronchioloalveolar carcinoma and the air bronchogram sign: a new pathologic explanation. J Thorac Imaging 1994;9:141-144 https://doi.org/10.1097/00005382-199422000-00004